Big Pharma CEOs get candid about pricing and M&A

[cafead]

via If you’re the CEO of one of the biggest pharma companies in the world, there’s likely a lot on your mind. With U.S. drug pricing negotiations on the table and volatility still roiling the biotech markets, molehills can become mountains in the blink of an eye.

article source